blood samples; colon cancer tissues
HT29; HCT116; HCT8; HT29-LOHP; HCT116-LOHP; HCT8-LOHP
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); drug resistance (promotes); inflammation (promotes)
RT-qPCR; Western Blot; Luciferase Reporter Assay; RNA Pull-Down; Co-IP; ELISA; Transfection; Transwell Assay; In Vivo Animal Model; BrdU; Flow Cytometry(Non-apoptosis/cycle); Bioinformatics Analysis
-
hsa_circ_0079662 is up-regulated in oxaliplatin-resistant CRC cell lines and promotes malignant phenotypes (growth, migration, invasion) and drug resistance. Mechanistically, it functions as a ceRNA sponging hsa-miR-324-5p to de-repress HOXA9, and is linked to increased inflammatory cytokines including TNF-alpha, supporting a TNF-alpha pathway-associated resistance mechanism.
0.6583
Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-alpha pathway in human colon cancer.
biological research